Minomic International specialises in the development of diagnostics for cancers such as prostate, bladder and pancreatic. In 2008, Minomic was subject to a takeover bid by Probiomics but the transaction did not go through.
Minomic International specialises in the development of diagnostics for cancers such as prostate, bladder and pancreatic. In 2008, Minomic was subject to a takeover bid by Probiomics but the transaction did not go through.